TARGETING THE PERIPHERAL T‐CELL LYMPHOMA (PTCL) EPIGENOME WITH ORAL 5‐AZACYTIDINE AND ROMIDEPSIN: RESULTS AND CLINICAL‐MOLECULAR CORRELATIONS FROM A PHASE 2 STUDY. (12th June 2019) - Falchi, L.; Lue, J.K.; Montanari, F.; Marchi, E.; Amengual, J.E.; Sawas, A.; Deng, C.; Khan, K.; Kim, H.A.; Rada, A.; Malanga, M.; Francescone, M.F.; et al.